New York, NY, United States of America

John M Hefton

This inventor holds 3 USPTO granted patents. Top assignees: Sloan-Kettering Institute for Cancer Research, Other. Active years: 1981-1991.


% Patents Active = 100.0

Average Co-Inventor Count = 1.2

ph-index = 3

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 1981-1991

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by John M Hefton

Introduction

John M Hefton is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medical technology, particularly in skin treatment and tissue engineering. With a total of 3 patents, Hefton's work has the potential to impact the lives of many patients requiring skin transplants.

Latest Patents

Hefton's latest patents include a method of treating the skin using human epidermal sheets. This innovative procedure involves eliminating immune competent cells from a population of human epidermal cells. The resulting cells, free of immune competent cells, are utilized for growing tissue sheets that are suitable for transplantation to recipients unrelated to the donor. Another significant patent is the process for growing human epidermis, which follows a similar methodology to ensure the production of viable tissue for transplantation.

Career Highlights

Throughout his career, John M Hefton has worked with prestigious institutions, including the Sloan Kettering Institute for Cancer Research. His research and inventions have contributed to advancements in the medical field, particularly in regenerative medicine.

Collaborations

Hefton has collaborated with various professionals in his field, including Magdalena G Eisinger. Their joint efforts have furthered research and development in skin treatment technologies.

Conclusion

John M Hefton is a distinguished inventor whose work in skin treatment and tissue engineering has the potential to revolutionize medical practices. His patents reflect a commitment to improving patient outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…